Concentration-QTcF Analysis of Quizartinib in Patients With Newly Diagnosed (ND) Acute Myeloid Leukemia (AML) ACoP13 (Nov 2022), Poster M-034 Vaddady P, Smania G, Bergstrand M, Nakayama S, Inoue H, Kurumaddali A, Abutarif M, Sheng M. ConferenceMIDDOncologyPharmacometricsRegulatory interactions Pharmetheus Affiliates Senior Consultant & Team Leader Giovanni Smania See bio Principal Consultant & MIDD Platform Scientific Lead Martin Bergstrand See bio
